Table 1.
Variable (Total N = 304) | N (%) |
---|---|
Male | 159 (52%) |
Age, y | |
<5 | 23 (8%) |
5–8 | 40 (13%) |
9–13 | 98 (32%) |
>13 | 143 (47%) |
Race/ethnicity | |
White | 166 (55%) |
Black | 97 (32%) |
Hispanic | 25 (8%) |
Other | 12 (4%) |
Missing | 4 |
Insurance | |
Private | 257 (90%) |
Medicare/Medicaid | 21 (7%) |
Uninsured | 8 (3%) |
Missing | 18 |
Distance to cancer center (mi) (IQR) | 16.1 (7.2, 36) |
Tumor size | |
≤4 cm | 101 (36%) |
4.1–7 cm | 75 (27%) |
7.1–10 cm | 55 (20%) |
>10 cm | 47 (17%) |
Missing | 26 |
Median tumor size, cm (IQR) | 5.5 (3, 8.9) |
Histologic type | |
Papillary | 48 (16%) |
Clear cell | 38 (12%) |
RCC NOS | 170 (56%) |
Other | 48 (16%) |
Pathologic stage | |
I | 83 (39%) |
II | 35 (16%) |
III | 70 (33%) |
IV | 26 (12%) |
Missing | 90 |
Surgical margins | |
Negative | 232 (91%) |
Positive margin | 22 (9%) |
Missing | 50 |
Positive nodes | 76 (30%) |
Missing | 54 |
Radiation | 12 (4%) |
Missing | 4 |
Chemotherapy | 58 (20%) |
Missing | 9 |